TY - CHAP
T1 - Optimal Antiplatelet Therapy
T2 - Duration of Antiplatelet Therapy with Drug-Eluting and Bare Metal Stents
AU - Roy, Probal
AU - Waksman, Ron
PY - 2009/10/30
Y1 - 2009/10/30
KW - Antiplatelet therapy
KW - Antiplatelet therapy in BMS era
KW - Antiplatelet therapy in DES era
KW - Coronary artery disease (CAD)
KW - Drug-eluting stents (DES)
KW - Optimal antiplatelet therapy with drug-eluting and bare metal stents
KW - Percutaneous coronary intervention (PCI)
KW - Sirolimus-eluting stent (SES) and paclitaxel-eluting stent (PES)
KW - Stent implantation-focal treatment of systemic process
KW - Sustained dual antiplatelet therapy on cardiac outcomes in CURE, PCI-CURE, and CREDO
UR - http://www.scopus.com/inward/record.url?scp=84889358043&partnerID=8YFLogxK
U2 - 10.1002/9781444306347.ch5
DO - 10.1002/9781444306347.ch5
M3 - Chapter
AN - SCOPUS:84889358043
SN - 9781405157049
SP - 31
EP - 40
BT - Pharmacology in the Catheterization Laboratory
PB - Wiley-Blackwell, Wiley
ER -